Drug Trial Radar · NCT01618669
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Last checked: Nov 20, 2026Latest source record: Feb 8, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,147
Actual
Start
Jun 2012
Primary completion
Dec 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- Astellas Pharma Global Development, Inc.Astellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Jun 13, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate that the strength of agreement between single photon emission computed tomography (SPECT) imaging with regadenoson following inadequate exercise stress testing and SPECT imaging with regadenoson alone is not inferior to the strength of agreement between two sequential regadenoson SPECT images without exercise.
Conditions
- Coronary Artery Disease (CAD)
Interventions
RegadenosonDrug
Administered as an intravenous (IV) bolus
Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)Procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants With Majority Reader Self-agreement in Ischemia Assessment Between First and Second Stress ScansTime frame: Day 1 (rest scan and first stress scan) and Day 2 -15 (second stress scan)
Locations
69 sites in 4 countries. Site status is shown where the registry gives one.
Mobile Heart Specialists, PC
Mobile, Alabama
Silicon Valley Medical Imaging
Fremont, California
Long Beach Memorial Medical Center
Long Beach, California
Cedars-Sinai Medical Center
Los Angeles, California
VA Greater Los Angeles Healthcare System
Los Angeles, California
Westside Medical Associates of Los Angeles
Los Angeles, California
Ventura Clinical Trials
Malibu, California
Mission Internal Medical Group
Mission Viejo, California
VA San Diego Healthcare System
San Diego, California
Santa Rosa Cardiology Medical Group, Inc.
Santa Rosa, California
Los Angeles Biomedical Research Institute
Torrance, California
HOCC - New Britain Campus
New Britain, Connecticut
Yale University
New Haven, Connecticut
Alfieri Cardiology
Newark, Delaware
Delaware Clinical Trials
Wilmington, Delaware
Elite Research and Clinical Trials
Aventura, Florida
S & W Clinical Research
Fort Lauderdale, Florida
Holy Cross Hospital
Fort Lauderdale, Florida
Florida Heart Associates
Fort Myers, Florida
East Coast Institute for Research, LLC
Jacksonville, Florida
St. Luke's Cardiology St. Vincent's HealthCare
Jacksonville, Florida
Watson Medical Clinic/Lakeland Regional Medical Clinic
Lakeland, Florida
MIMA Century Research Associates
Melbourne, Florida
Cardiovascular Research Center of South Florida
Miami, Florida
Florida Hospital/Cardiovascular Institute
Orlando, Florida
University of South Florida
Tampa, Florida
Cardiology Partners Clinical Research Institute
Wellington, Florida
St. Joseph's Hospital
Atlanta, Georgia
University Cardiology Associates, LLC
Augusta, Georgia
South Coast Medical Group
Savannah, Georgia
Rush University Medical Center
Chicago, Illinois
I U School of Medicine/ Krannert Institute of Cardiology
Indianapolis, Indiana
Midwest Cardiology Associates
Overland Park, Kansas
Maine Research Associates
Portland, Maine
University of Maryland
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Berkshire Medical Center
Pittsfield, Massachusetts
Henry Ford Hospital
Detriot, Michigan
Wayne State University
Detroit, Michigan
Michigan Heart
Ypsilanti, Michigan
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.